MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with a focus on industrial safety applications in South America's mining sector. The company recently appointed Chilean policy specialist Felipe Leyton to lead commercialization efforts in the region, signaling a transition from technology development to field implementation in large enterprise environments.
Leyton brings extensive experience in national drug policy and workplace safety, having helped design and implement Chile's 'Zero Tolerance' alcohol-impaired driving law as part of the country's alcohol prevention framework. He also played a role in establishing Chile's roadside drug testing program introduced in 2019. His appointment reflects MindBio's strategy of aligning technical development with regulatory and industry expertise in markets where impairment detection is closely tied to workplace safety and compliance requirements.
MindBio is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy using only the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for detection in environments such as mining, aviation, construction, and law enforcement.
The move toward commercial deployment in South America is significant given the region's large mining industry, where impairment detection is critical for safety. The appointment of Leyton, with his background in policy and enforcement, positions MindBio to navigate regulatory landscapes and build trust with enterprise clients. As the company transitions from development to deployment, its technology could set a new standard for workplace safety in high-risk industries. More details are available in the full article at https://ibn.fm/JBNVq.
For the latest news and updates relating to MBQIF, visit the company's newsroom at https://ibn.fm/MBQIF.
